Caprock Group’s Boston Scientific BSX Stock Holding History

Caprock Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	$6.13M	Buy	60,766 +8,931	+17%	+$901K	0.19%	91
2024 Q4	$4.63M	Buy	51,835 +5,323	+11%	+$475K	0.15%	109
2024 Q3	$3.9M	Buy	46,512 +3,686	+9%	+$309K	0.14%	122
2024 Q2	$3.3M	Buy	42,826 +16,348	+62%	+$1.26M	0.13%	127
2024 Q1	$1.81M	Sell	26,478 -34	-0.1%	-$2.33K	0.1%	149
2023 Q4	$1.53M	Buy	26,512 +1,417	+6%	+$81.9K	0.1%	170
2023 Q3	$1.32M	Sell	25,095 -543	-2%	-$28.7K	0.1%	162
2023 Q2	$1.39M	Buy	25,638 +1,830	+8%	+$99K	0.1%	160
2023 Q1	$1.19M	Buy	23,808 +3,337	+16%	+$167K	0.09%	169
2022 Q4	$947K	Buy	20,471 +2,538	+14%	+$117K	0.09%	182
2022 Q3	$695K	Buy	17,933 +1,490	+9%	+$57.7K	0.07%	212
2022 Q2	$613K	Buy	16,443 +1,869	+13%	+$69.7K	0.06%	234
2022 Q1	$645K	Buy	14,574 +4,313	+42%	+$191K	0.06%	242
2021 Q4	$436K	Buy	10,261 +1,206	+13%	+$51.2K	0.04%	323
2021 Q3	$393K	Buy	9,055 +144	+2%	+$6.25K	0.04%	314
2021 Q2	$381K	Sell	8,911 -2,271	-20%	-$97.1K	0.03%	305
2021 Q1	$432K	Buy	11,182 +3,649	+48%	+$141K	0.05%	263
2020 Q4	$271K	Sell	7,533 -3,690	-33%	-$133K	0.03%	352
2020 Q3	$429K	Buy	11,223 +1,051	+10%	+$40.2K	0.06%	232
2020 Q2	$357K	Buy	10,172 +1,821	+22%	+$63.9K	0.05%	252
2020 Q1	$272K	Sell	8,351 -2,291	-22%	-$74.6K	0.05%	253
2019 Q4	$481K	Buy	10,642 +315	+3%	+$14.2K	0.09%	173
2019 Q3	$420K	Sell	10,327 -84	-0.8%	-$3.42K	0.08%	179
2019 Q2	$447K	Sell	10,411 -2,419	-19%	-$104K	0.09%	173
2019 Q1	$492K	Buy	12,830 +634	+5%	+$24.3K	0.1%	176
2018 Q4	$431K	Buy	12,196 +981	+9%	+$34.7K	0.1%	178
2018 Q3	$432K	Buy	11,215 +92	+0.8%	+$3.54K	0.09%	192
2018 Q2	$364K	Buy	+11,123	New	+$364K	0.08%	236
2017 Q1	–	Sell	-12,979	Closed	-$281K	–	357
2016 Q4	$281K	Sell	12,979 -631	-5%	-$13.7K	0.07%	240
2016 Q3	$324K	Buy	+13,610	New	+$324K	0.07%	240